Sliptin-M ER 50 mg+500 mg (Tablet (Extended Release))
Unit Price: ৳ 16.05 (2 x 7: ৳ 224.70)
Strip Price: ৳ 112.35
Medicine Details
Category | Details |
---|---|
Generic | Sitagliptin metformin hydrochloride |
Company | Drug international ltd |
Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
- Limitations of use
- Not for type 1 diabetes
- Not for treatment of diabetic ketoacidosis
- Not studied in pancreatitis patients
Pharmacology
- Combines two antihyperglycemic agents
- Complementary mechanisms of action
- Dipeptidyl peptidase-4 (DPP-4) Inhibitor
- Biguanide class
- Incretin hormones regulation
- Physiological regulation of glucose homeostasis
- GLP-1 and GIP hormone effects
- Insulin and glucagon regulation
- Glucose uptake and utilization
- Hepatic glucose production
Dosage & Administration
- Individualized dosage
- Maximum recommended daily dose
- Twice daily with meals
- Gradual dose escalation
- Reducing gastrointestinal side effects
- Starting dose based on current regimen
- Extended-release tablet dosing
- Insulin and insulin secretagogue co-administration
Interaction
- Cationic drugs caution
- Phenprocoumon effect
- Levothyroxine impact on hypoglycemic effect
Contraindications
- Renal disease or dysfunction
- Metabolic acidosis
- History of hypersensitivity reaction
- Radiologic studies precaution
Side Effects
- Common adverse reactions
- Specific reactions for different treatment combinations
- Metformin therapy adverse reactions
Pregnancy & Lactation
- Pregnancy Category B
- Safety during pregnancy
- Excretion in human milk caution
Precautions & Warnings
- Lactic Acidosis risk factors and symptoms
- Thyroid-stimulating hormone monitoring
- Vitamin B12 level monitoring
- Hepatic disease caution
- Renal function assessment
- Pancreatitis risk
- Hematologic parameters monitoring
- Alcohol intake warning
- Insulin use during stress
- Allergic and hypersensitivity reactions
- Macrovascular risk reduction
Overdose Effects
- Sitagliptin overdose measures
- Sitagliptin dialyzability
- Metformin hydrochloride overdose and dialyzability
- Pancreatitis in metformin overdose
Therapeutic Class
- Combination oral hypoglycemic preparations
Storage Conditions
- Temperature and light storage
- Keep away from children
- Expiry date importance
- Dispensing only on prescription
Related Brands
- Sitacret-M 50 mg+500 mg (Tablet) - renata-limited
- Sitafit 50 mg+500 mg (Tablet) - team-pharmaceuticals-ltd
- Janmet XR 50 mg+500 mg (Tablet (Extended Release)) - acme-laboratories-ltd
- Radiglip-M 50 mg+1000 mg (Tablet (Extended Release)) - radiant-pharmaceuticals-ltd
- Taglimet 50 mg+500 mg (Tablet) - ibn-sina-pharmaceuticals-ltd